TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$25 Million

Viveve Medical

At-the-market Offering

Viveve is a women’s intimate health company that markets medical devices for the non-invasive treatment of various post-partum conditions. The Company utilizes its internationally patented, cryogen-cooled monopolar radiofrequency (CMRF) technology, which is the only energy-based device in women’s health that uses cryogen cooling. The GENEVEVE treatment is a non-invasive solution to treat vaginal introital laxity that uses a radio frequency generator housed in a table-top console (the Viveve System), a reusable hand piece and a single-use treatment tip, as well as several other consumable accessories.